Request Customization - Radiopharmaceuticals Market Size, Share & Growth Report By 2030

Global Radiopharmaceuticals Market Research Report: Forecast (2025-2030)

Radiopharmaceuticals Market - By Radioisotope (Technetium 99, Fluorine 18, Iodine 131, Gallium 68, Iodine 123, Others), By Indication (Oncology, Cardiology, Gastroenterology, Nephrology, Others), By T... ... ology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals, Medical Imaging Centers) and Others, Read more

Healthcare
Nov 2024
Pages 192
Report Format: PDF, Excel, PPT

Market Definition

Radiopharmaceuticals are specialized medications comprising a carrier molecule, often a pharmaceutical agent or biomolecule, combined with a radioactive isotope. These compounds emit radiation that can be detected by imaging devices for diagnostic purposes or deliver targeted radiation therapy to treat diseases, such as cancer.

Market Insights & Analysis: Global Radiopharmaceuticals Market (2025-30):

The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30. With the increasing burden of the geriatric population, the incidence of multiple diseases, including cancer, cardiovascular diseases (CVDs), etc., is expected to increase enormously across the world. According to the American Society of Clinical Oncology (ASCO), most people who are diagnosed with cancer are older than 65. As a result, the adoption of radiopharmaceuticals for the diagnosis as well as the treatment of cancer, CVDs, and other diseases would increase, propelling the overall Radiopharmaceuticals Market. For instance, as per the World Health Organisation (WHO), it has been estimated that by 2030, the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. Further, the world’s population of people aged 60 years and older will reach around 2.1 billion by 2050.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2024	USD 7.11 billion
Market Value By 2030	USD 12.73 billion
CAGR (2025-30)	10.19%
Leading Region	North America
Top Key Players	Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, various awareness programs and initiatives are promoting early disease diagnosis and treatment across the world. These efforts by both government and non-government organizations encourage individuals to undergo regular health check-ups, including full-body screenings, to detect diseases like cancer at early stages when treatment is more effective.

Following that, the adoption of radiopharmaceuticals that have a crucial role to play in various diagnostic procedures, including imaging techniques, like positron emission tomography (PET) scans, which can detect abnormalities & diseases, such as cancer has witnessed a rise. Hence, with that, the Global Radiopharmaceuticals Market is presumed to flourish in the following years.

Market Segmentation
Introduction
1. Radioisotope Definition
2. Research Process
3. Assumptions
Executive Summary
Global Radiopharmaceuticals Market Trends & Developments
Global Radiopharmaceuticals Market Dynamics
1. Drivers
2. Challenges
Global Radiopharmaceuticals Market Hotspot & Opportunities
Global Radiopharmaceuticals Market Supply Chain Analysis
Global Radiopharmaceuticals Market Regulations and Policy
Global Radiopharmaceuticals Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Size & Analysis
  1. By Radioisotope
    1. Technetium 99- Market Size & Forecast 2020-2030, USD Million
    2. Fluorine 18- Market Size & Forecast 2020-2030, USD Million
    3. Iodine 131- Market Size & Forecast 2020-2030, USD Million
    4. Gallium 68- Market Size & Forecast 2020-2030, USD Million
    5. Iodine 123- Market Size & Forecast 2020-2030, USD Million
    6. Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million
  2. By Indication
    1. Oncology- Market Size & Forecast 2020-2030, USD Million
    2. Cardiology- Market Size & Forecast 2020-2030, USD Million
    3. Gastroenterology- Market Size & Forecast 2020-2030, USD Million
    4. Nephrology- Market Size & Forecast 2020-2030, USD Million
    5. Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million
  3. By Type
    1. Diagnostic- Market Size & Forecast 2020-2030, USD Million
    2. Therapeutic- Market Size & Forecast 2020-2030, USD Million
  4. By End User
    1. Hospitals- Market Size & Forecast 2020-2030, USD Million
    2. Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million
    3. Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  6. By Competition
    1. Competition Characteristics
    2. Market Share of Companies
North America Radiopharmaceuticals Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
  2. By Indication- Market Size & Forecast 2020-2030, USD Million
  3. By Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. Canada Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
5. Mexico Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
South America Radiopharmaceuticals Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
  2. By Indication- Market Size & Forecast 2020-2030, USD Million
  3. By Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
Europe Radiopharmaceuticals Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
  2. By Indication- Market Size & Forecast 2020-2030, USD Million
  3. By Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. The UK Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
5. France Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
6. Spain Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
7. Italy Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
The Middle East & Africa Radiopharmaceuticals Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
  2. By Indication- Market Size & Forecast 2020-2030, USD Million
  3. By Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. GCC
    2. South Africa
    3. Rest of the Middle East & Africa
3. GCC Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD MillioN
4. South Africa Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
Asia-Pacific Radiopharmaceuticals Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
  2. By Indication- Market Size & Forecast 2020-2030, USD Million
  3. By Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. China
    2. Japan
    3. Australia
    4. South Korea
    5. India
    6. Rest of Asia-Pacific
3. China Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. Japan Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
5. Australia Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
6. South Korea Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
7. India Radiopharmaceuticals Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
Global Radiopharmaceuticals Market Key Strategic Imperatives for Growth & Success
Competitive Outlook
1. Company Profiles
  1. Bayer AG
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Iso-Tex Diagnostics, Inc.
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Jubilant Pharmova Limited
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Novartis AG
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. General Electric Company
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Lantheus Holdings, Inc.
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Eli Lilly and Company
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Siemens Healthineers AG
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Curium Pharma
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Cardinal Health
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Blue Earth Diagnostics, Inc. (Bracco Group)
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Acrotech Biopharm
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Northstar Medical Technologies LLC
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. IBA Radiopharma Solutions
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Sun Pharmaceutical Industries, Inc.
    1. Business Description
    2. Radioisotope Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Name *

Email *

Country *